The past 2 years have seen several major advances in oncolytic virotherapy. Studies on the interaction between viruses, immune responses and tumor microenvironment have provided important insight, while clinical trials have shown promise. This review summarizes key findings in this field over the past 2 years, and provides directions for future success.

Original languageEnglish
Pages (from-to)877-884
Number of pages8
JournalGene therapy
Issue number12
StatePublished - Jun 2008


Dive into the research topics of 'Gene therapy progress and prospects cancer: Oncolytic viruses'. Together they form a unique fingerprint.

Cite this